Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linqi Zhang

Showing results (231-240 of 279) with videos related to

Pageof 28
Sort By:
Journal of Virology|January 13, 2012
A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 virusesHongxing Hu, Jarrod Voss, Guoliang Zhang, et al.
Abdominal Radiology (New York)|March 2, 2021
Evaluation of MR elastography for prediction of lymph node metastasis in prostate cancerBing Hu, Ying Deng, Jingbiao Chen, et al.
European Radiology|May 23, 2021
Comparison of the diagnostic performance of 2D and 3D MR elastography in staging liver fibrosisMengsi Li, Hao Yang, Yong Liu, et al.
Frontiers in Molecular Biosciences|June 27, 2022
Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in AsiansZongyi Wang, Jiyang Tang, Enzhong Jin, et al.
Journal of Virology|November 27, 2004
Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in chinaLinqi Zhang, Zhiwei Chen, Yunzhen Cao, et al.
Nature Communications|November 17, 2021
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virusQian-Ying Zhu, Sisi Shan, Jinfang Yu, et al.
Scientific Reports|May 17, 2016
Potent neutralizing monoclonal antibodies against Ebola virus infectionQi Zhang, Miao Gui, Xuefeng Niu, et al.
Journal of Virology|February 12, 2002
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyXia Jin, Murugappan Ramanathan, Shady Barsoum, et al.
Cell Discovery|December 19, 2021
Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infectionJiaojiao Liu, Kun Xu, Man Xing, et al.
Immunity|June 24, 2021
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional speciesRuoke Wang, Qi Zhang, Jiwan Ge, et al.
Pageof 28

Showing results (231-240 of 279) with videos related to

Sort By:
Pageof 28
Journal of Virology|January 13, 2012
A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 virusesHongxing Hu, Jarrod Voss, Guoliang Zhang, et al.
Abdominal Radiology (New York)|March 2, 2021
Evaluation of MR elastography for prediction of lymph node metastasis in prostate cancerBing Hu, Ying Deng, Jingbiao Chen, et al.
European Radiology|May 23, 2021
Comparison of the diagnostic performance of 2D and 3D MR elastography in staging liver fibrosisMengsi Li, Hao Yang, Yong Liu, et al.
Frontiers in Molecular Biosciences|June 27, 2022
Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in AsiansZongyi Wang, Jiyang Tang, Enzhong Jin, et al.
Journal of Virology|November 27, 2004
Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in chinaLinqi Zhang, Zhiwei Chen, Yunzhen Cao, et al.
Nature Communications|November 17, 2021
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virusQian-Ying Zhu, Sisi Shan, Jinfang Yu, et al.
Scientific Reports|May 17, 2016
Potent neutralizing monoclonal antibodies against Ebola virus infectionQi Zhang, Miao Gui, Xuefeng Niu, et al.
Journal of Virology|February 12, 2002
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyXia Jin, Murugappan Ramanathan, Shady Barsoum, et al.
Cell Discovery|December 19, 2021
Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infectionJiaojiao Liu, Kun Xu, Man Xing, et al.
Immunity|June 24, 2021
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional speciesRuoke Wang, Qi Zhang, Jiwan Ge, et al.
Pageof 28